Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 8NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other 1

Conditions

Urinary Incontinence 2Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1Prostatic Hyperplasia 1Neoplasms 1

Interventions

Cyclophosphamide 385Specimen Handling 371Magnetic Resonance Spectroscopy 325Radiotherapy 306Biopsy 269Cisplatin 257Carboplatin 253Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 182Bevacizumab 180Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 140Taxes 127Docetaxel 122Oxaliplatin 113Chemotherapy, Adjuvant 113fludarabine phosphate 111Rituximab 107Methotrexate 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Interventional × Biofeedback, Psychology × Clear all
NCT00212264 2016-04-11

Conservative Treatment of Postprostatectomy Incontinence

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase NA Completed
208 enrolled 9 charts
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

National Cancer Institute (NCI)

Phase 3 Completed
800 enrolled
GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡